OneDash Definitions
OneDash may use terms that you are not familiar with.
To help you use to platform efficiently, they are defined for you here!
OneDash Terms
Term | Definition |
|---|---|
Category | A collection of rules |
Care Gap | Generated from a rule, a recommended action to take on an individual member |
Owner | The user or team of users that is assigned to all activities related to a rule, automation, intervention, or intervention action |
Parameter | A defined string of filters with applied logic |
Population | A cohort of members in which you would like to apply a parameter to |
Rules | A parameter applied to a specific population, that is run at a specified frequency to generate interventions |
Run Frequency | The frequency at which a rule will be automatically run |
Tag | A way to name and save a specific population of interest |
Clinical Terms
General
Term | Definition |
|---|---|
PDC (Proportion of Days Covered) | A CMS-adopted measure for adherence; % of days a patient has medication on hand. |
Days Covered | The number of days that are covered by a respective medication or medication class. |
Best End of Year PDC | Reflects highest possible PDC that can be acheived by the end of the year for that member. This assumes that all future days in the year are covered by a medication in the measure's medication class. |
Worst End of Year PDC | Reflects lowest possible PDC that can be acheived by the end of the year for that member. This assumes that all future days in the year are NOT covered by a medication in the measure's medication class. |
Star Measures
Definitions from Acumen
Term | Definition |
|---|---|
ADH-Diabetes | The percentage of continuously enrolled (CE) Medicare Part D beneficiaries1, 18 years or older, who were adherent across the following classes of diabetes medications: BG, SFU, TZD, DPP-4 inhibitors, GIP/GLP-1 receptor agonists, MEG, and SGLT2 inhibitors. |
ADH-RAS | The percentage of CE Medicare Part D beneficiaries, 18 years or older, who were adherent to RAS antagonists including, ACE inhibitors, ARBs, or Direct Renin Inhibitors. |
ADH-Statin | The percentage of CE Medicare Part D beneficiaries, 18 years or older, who were adherent to statins. |
SUPD | The percentage of continuously enrolled (CE) Medicare Part D beneficiaries, ages 40 to 75 years, who were dispensed medications for diabetes and received a statin medication during the measurement period. |
COB | The percentage of continuously enrolled (CE) Medicare Part D beneficiaries, 18 years or older, with concurrent use of prescription opioids and benzodiazepines during the measurement period. |
Poly-ACH | The percentage of CE Medicare Part D beneficiaries, 65 years or older, with concurrent use of two or more unique ACH medications during the measurement period. |
HEDIS Measures
Definitions from HEDIS Tech Specs
Term | Definition |
|---|---|
AMR (Asthma Medication Ratio) | The percentage of members 5–64 years of age who were identified as having persistent asthma and had a ratio of controller medications to total asthma medications of 0.50 or greater during the measurement year. |
COU (Risk of Continued Opioid Use) | The percentage of members 18 years of age and older who have a new episode of opioid use that puts them at risk for continued opioid use. Two rates are reported:
Note: A lower rate indicates better performance. |
HDO (Use of Opioids at High Dosage) | The percentage of members 18 years of age and older who received prescription opioids at a high dosage (average morphine milligram equivalent dose [MME] ≥90) for ≥15 days during the measurement year. Note: A lower rate indicates better performance. |
PBH (Persistence of Beta-Blocker Treatment After a Heart Attack) | The percentage of members 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of AMI and who received persistent beta-blocker treatment for 180 days (6 months) after discharge. |
PCE (Pharmacotherapy Management of COPD Exacerbation) | The percentage of COPD exacerbations for members 40 years of age and older who had an acute inpatient discharge or ED visit on or between January 1–November 30 of the measurement year and who were dispensed appropriate medications. Two rates are reported:
Note: The eligible population for this measure is based on acute inpatient discharges and ED visits, not on members. It is possible for the denominator to include multiple events for the same individual. |
SAA (Adherence to Antipsychotic Medications for Individuals With Schizophrenia) | The percentage of members 18 years of age and older during the measurement year with schizophrenia or schizoaffective disorder who were dispensed and remained on an antipsychotic medication for at least 80% of their treatment period. |
SPC (Statin Therapy for Patients With Cardiovascular Disease) | The percentage of males 21–75 years of age and females 40–75 years of age during the measurement year who were identified as having clinical atherosclerotic cardiovascular disease (ASCVD) and met the following criteria. The following rates are reported:
|
SPD (Statin Therapy for Patients With Diabetes) | The percentage of members 40–75 years of age during the measurement year with diabetes who do not have clinical atherosclerotic cardiovascular disease (ASCVD) who met the following criteria. Two rates are reported:
|
UOP (Use of Opioids From Multiple Providers) | The percentage of members 18 years and older, receiving prescription opioids for ≥15 days during the measurement year, who received opioids from multiple providers. Three rates are reported.
Note: A lower rate indicates better performance for all three rates. Definitions |